Work

205 Discovery and Development of Bardoxolone Methyl, an Antioxidant Inflammation Modulator (AIM) Targeting the KEAP1-NRF2 Pathway

Year: 2011

Type: article

Source: American Journal of Kidney Diseases

DOI: 10.1053/j.ajkd.2011.02.208

Authors: Colin J. Meyer, W. Christian Wigley, Deborah A. Ferguson, J. Warren Huff, Robin Kral, Karen T. Liby, Michael B. Sporn

Institutions: Reata Pharmaceuticals (United States), Dartmouth College

Language: English

Topic: Genomics, phytochemicals, and oxidative stress

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1995337670

FWCI: 0.107

Cites:

Cited by: 1

Related to: 10